Antiserum in Biological Products
Navigation Links
Antiserum in Biological Products
Guanylate Cyclase Blocking Peptide from Cayman Chemical
Description:... to the same sequence used as antigens for guanylate cyclase polyclonal antiserum (Catalog No. 160890) To be used in conjunction with Cayman's guanylate cyclase polyclonal antiserum (Catalog No. 160890) to block protein-antibody complex formation during ...Company:Cayman Chemical
Anti-Glycine Transporter 2, Neuronal (GLYT2) Polyclonal Antibody, Unconjugated from CHEMICON
Description:... Glycine Transporter 2, Neuronal (GLYT2). The antiserum has been tested on tissue sections from the central nervous system. The ... to what has been described for glycinergic neurons. Preabsorption of the antiserum with the immunogen peptide completely abolishes the ....Company:CHEMICON
Rabbit Anti-L-isoleucine Antibody, Unconjugated from QED Bioscience Inc.
Description:... Polyclonal antiserum raised against conjugated L-isoleucine. Available as antiserum. Amino Acid ...Company:QED Bioscience Inc.
Anti-11-keto Testosterone (EIA Antiserum) Antibody, Unconjugated from Cayman Chemical
Description:... 11-keto Testosterone EIA antiserum hormones steroids antisera antiserum eias enzyme immunoassays reagents ...Company:Cayman Chemical
Rabbit Anti-MAGE-D2 / NRAGE-Like 2b Polyclonal Antibody, Unconjugated from Upstate
Description:... Number : NM_201222 Immunogen : peptide (C-QSQENQDTRPKVKAKK), corresponding to amino acids 161-176 of human MAGE-D2/NRAGE-Like 2b Formulation: antiserum in 0.05% sodium azide and 30% glycerol Quality Assurance: routinely evaluated by immunoblot on HEK 293 cell lysates Recognizes MAGE-D2/NRAGE-Like ...Company:Upstate
Phospho-peptide Antibody from Proteintech Group, Inc.
Description:... bleed (app. 5 ml) x1 /each Production bleed (15 ml) x2 /each Final Bleed ~ 50 ml x1 each Free ELISA x1/each Purification of antiserum over antigen (30 ml) Conjugation of antigen peptide to Sepharose, 3 ml column Written report of antibody characterization including amount ...Company:Proteintech Group, Inc.
Description:... Glycoprotein Preservative: 0.1% sodium azide Goats were immunized with highly purified human Alpha-1-acid glycoprotein in Freund's adjuvant. The antiserum was solid phase absorbed to ensure specificity. For Research and Manufacturing Only; Not for Use in Diagnostic ....
Company:Immunology Consultants Laboratory, Inc.
COX-1 Blocking Peptide from Cayman Chemical
Description:... Peptide Sequence: ovine COX-1 amino acids 272-282 (LMHYPRGIPPQ) To be used in conjunction with Cayman's COX-1 (ovine) polyclonal antiserum (Catalog No. 160108) to block protein-antibody complex formation during analysis for ....Company:Cayman Chemical
Anti-Sheep/Goat Sac-Cel - Solid-phase Separation System from IDS Ltd
Description:... and the enhanced sensitivity that this confers. Sac-Cel has been formulated to address the IgG fraction of the major host species for primary antiserum development, namely rabbit, sheep/goat, guinea pig, and mouse/rat. Sac-Cel has also been used for affinity purification, and a host of other ...Company:IDS Ltd
Rabbit Anti-NPY Y2 Receptor Polyclonal Antibody, Unconjugated from GeneTex
Description:... Rabbit polyclonal NPY Y2 Receptor antiserum This NPY Y2 antibody has been extensively characterized at the spinal level and is currently being characerized in brain. The antibody has been ...Company:GeneTex
Rabbit Anti-Dideoxycytidine Polyclonal Antibody, Unconjugated from GeneTex
Description:... be effective in inhibiting retroviral activity. Immunogen: Chemical / Small Molecule conjugated to BSA. Specificity: The specificity of the ddC antiserum was determined by calculating the ratio of the moles of ddC to moles of ddC analog at the 50% intercept of the respective dose response curves and ...Company:GeneTex
Rabbit Anti-Rat Neuromedin Antibody, Unconjugated from BACHEM
Description:... Neuromedin U-23 (rat) - Diluted antiserum for RIA, Host: Rabbit Family: Neuromedin U-23 (rat) Immunology Products, Host: Rabbit Antigen sequence: ...Company:BACHEM
Other ContentsfemoralfemoralfemoralfertilityfertilityfertilityfertilityfertilityfertilityfertilityfertilityblisterblisterblisterblistersblistersblistersfiberfiberfiberfiberfiberfiberfiberfiberfetalfetalfetalfetalfetalfetalfetalfetalfetalfibromyalgiafibromyalgiaOther TagsBooBooBooBooMatedMatedMatedMatedOther Tagstermed 2termed 3termed 4termed 5termed 6termed 7termed 8attitudes 2attitudes 3attitudes 4attitudes 5attitudes 6attitudes 7types 2types 3types 4types 5types 6types 7types 8types 9types 10apart 2apart 3apart 4apart 5tease 2
(Date:11/26/2009)... Aureus ) and other drug-resistant bacteria could ...ype devices have been developed to offer safe, qui... Two prototype devices have been developed: one fo...ds and feet) in hospitals and public spaces where ...shoot bacteria-killing agents into infested chroni...
(Date:11/25/2009)...ers and ambulance workers faced a terrifying rescu...attled to save people from the collapsing Twin Tow...cuated as many people as they could in an area whi...g their jobs even harder was the problem of poor c...ves jammed mobile networks with calls and the emer...
(Date:11/25/2009)...ors recently received funding from the National Sc...cial to understanding the environment. The three g...ssistant professor in the Department of Biological...ate research projects. , His first project, titl...unctions from the Leaf to the Landscape," will exa...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Magic box for mission impossible 2Magic box for mission impossible 3Kent State University professors focus research on the environment with grants totaling $890,000 2Bonus Payout Trends and Continuing Cost Controls Reflect Challenging Business Climate Says Aon Consultings Radford 48659 1Bonus Payout Trends and Continuing Cost Controls Reflect Challenging Business Climate Says Aon Consultings Radford 48659 2Bonus Payout Trends and Continuing Cost Controls Reflect Challenging Business Climate Says Aon Consultings Radford 48659 3Bonus Payout Trends and Continuing Cost Controls Reflect Challenging Business Climate Says Aon Consultings Radford 48659 4Actuaries Weigh in on Ways to Address Risk Exposures and Challenges with the U S Health Care System 48656 1Actuaries Weigh in on Ways to Address Risk Exposures and Challenges with the U S Health Care System 48656 2Actuaries Weigh in on Ways to Address Risk Exposures and Challenges with the U S Health Care System 48656 3Actuaries Weigh in on Ways to Address Risk Exposures and Challenges with the U S Health Care System 48656 4Cornflakes White Bread Could Boost Heart Risk 48653 1Cornflakes White Bread Could Boost Heart Risk 48653 2Cornflakes White Bread Could Boost Heart Risk 48653 3(Date:11/25/2009)...v.25/PRNewswire-FirstCall/-- OnyxPharmaceuticals,...lhosttwoinvestoreventsinDecember: ,, ASHBrief...T ,, Principalinvestigatorswilldiscussdatapre...fractorymultiplemyeloma,asfeaturedatthe51stAmerica...ninNewOrleans,LA.Theteleconferencewillbeginat9:00a...
(Date:11/25/2009)....25/PRNewswire-USNewswire/--AnarticlebyJanetWoodco...ndResearch,titled"ADifficultBalance-PainManagement...eofTheNewEnglandJournalofMedicine. ,, (Logo: ht... ) ,, Inthearticle,WoodcockdiscussesFDAeffortst...sewhoneeditandmanagingtherisksposedbyvariousanalge...
(Date:11/25/2009)...ticular cancer who were treated with cisplatin-bas...uding neurological side effects and Raynaud-like p...therapy, according to a new study published online...r Institute . , Marianne Brydy, M.D., of the Dep..., in Bergen, Norway, and colleagues conducted a cr...
(Date:11/25/2009)...as too short to draw definite conclusions, experts... News) -- In diabetic patients with blocked corona...outcomes at one year whether patients undergo bypa...esearchers report. , Bypass surgery has been th...ronary artery disease. However, less invasive appr...
(Date:11/25/2009)...eurological symptoms, study finds , , W... side effects are among the potential problems fac... were treated with cisplatin-based chemotherapy, a...9 Norwegian men treated for unilateral testicular ...llow-up survey conducted from 1998 to 2002. , T...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3[0] Onyx Pharmaceuticals Announces December 2009 Investor Events[1] FDA's Woodcock Discusses Pain Management and Drug Safety in Nov. 26, 2009 Issue of The New England Journal of Medicine[1] News brief: Long-term testicular cancer survivors at high risk for neurological side effects[1] Stenting May Equal Bypass for Diabetic Heart Patients [0] Long-Term Problems Linked to Testicular Cancer Chemo
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |